This trend aligns with the TIM-HHT trial, where timolol did not achieve significance but showed borderline improvements in bleeding scores [ 41 ].
← all excerpts
Propranolol Reduces Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Large Retrospective Study.
1
—
—